SCHEMBL7148215

SCHEMBL7148215

CCCCCCCCCC(N)C(=O)C(N)=O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 2/20 0.50
GRIK2 Q13002 2/20 0.50
GNAI3 P08754 1/20 0.49
GNAO1 P09471 1/20 0.49
GNAI1 P63096 1/20 0.49
SLC1A2 P43004 1/20 0.47
SLC1A1 P43005 1/20 0.47
DPP7 Q9UHL4 1/20 0.47
LAP3 P28838 2/20 0.47
GPR84 Q9NQS5 3/20 0.45
SPHK1 Q9NYA1 1/20 0.45
FFAR1 O14842 1/20 0.45
ZDHHC7 Q9NXF8 1/20 0.44
MAPT P10636 1/20 0.44
TP53 P04637 1/20 0.44
LCK P06239 1/20 0.44
PPARD Q03181 1/20 0.44
ZDHHC20 Q5W0Z9 1/20 0.44
ZDHHC2 Q9UIJ5 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8813489 0.98 GRIK1 (0.48) GRIK1GRIK2GNAI3GNAO1GNAI1
SCHEMBL5968482 0.91 DPP7 (0.50) GRIK1GRIK2SLC1A2SLC1A1DPP7
SCHEMBL29565162 0.83 GRIK1 (0.55) GRIK1GRIK2GNAI3GNAO1GNAI1
SCHEMBL8425258 0.83 GRIK1 (0.53) GRIK1GRIK2GNAI3GNAO1GNAI1
SCHEMBL28888696 0.83 GRIK1 (0.53) GRIK1GRIK2GNAI3GNAO1GNAI1
SCHEMBL14038058 0.83 GRIK1 (0.53) GRIK1GRIK2GNAI3GNAO1GNAI1
SCHEMBL2920941 0.83 GRIK1 (0.53) GRIK1GRIK2GNAI3GNAO1GNAI1
SCHEMBL18151772 0.83 GRIK1 (0.53) GRIK1GRIK2GNAI3GNAO1GNAI1
SCHEMBL6762998 0.83 GRIK1 (0.53) GRIK1GRIK2GNAI3GNAO1GNAI1
SCHEMBL27539628 0.83 GRIK1 (0.53) GRIK1GRIK2GNAI3GNAO1GNAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448394-B1 FORMATION OF BLOCKED ISOCYANTES WITHOUT FREE ISOCYANATE PRESENT BY REACTING AMINE WITH CARBONIC ACID DERIVATIVE DSM N.V. (NL) 2002-09-10 US claimed
US-20030088020-A1 Powder paint binder composition DSM N.V. (NL) 2003-05-08 US disclosed
EP-1263829-A1 POWDER PAINT BINDER COMPOSITION DSM N.V. (NL) 2002-12-11 EP disclosed
US-6448394-B1 FORMATION OF BLOCKED ISOCYANTES WITHOUT FREE ISOCYANATE PRESENT BY REACTING AMINE WITH CARBONIC ACID DERIVATIVE DSM N.V. (NL) 2002-09-10 US disclosed
US-20020028932-A1 Process for the preparation of an N-alkyl or N-aryl carbamoyl derivative DSM IP ASSETS B.V. (NL) 2002-03-07 US disclosed
WO-2001064769-A1 POWDER PAINT BINDER COMPOSITION DSM N.V. (NL) 2001-09-07 WO disclosed
EP-1130039-A1 Powder paint binder composition DSM N.V. (NL) 2001-09-05 EP disclosed
EP-1115709-A1 PROCESS FOR THE PREPARATION OF AN N-ALKYL OR N-ARYL CARBAMOYL DERIVATIVE DSM N.V. (NL) 2001-07-18 EP disclosed
WO-2000017169-A1 PROCESS FOR THE PREPARATION OF AN N-ALKYL OR N-ARYL CARBAMOYL DERIVATIVE DSM N.V. (NL) 2000-03-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020028932-A1 Process for the preparation of an N-alkyl or N-aryl carbamoyl derivative OGDH, DOHH, CFH GRIK1 2140/4885GRIK2 3015/4885GNAI3 1554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.